21 studies found for:    Open Studies | "Rhinitis, Allergic, Seasonal"
Show Display Options
Rank Status Study
1 Unknown  Observational Study With PASCALLERG ® in Patients With Hay Fever
Condition: Hay Fever
Intervention:
2 Not yet recruiting Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: GSP 301 NS;   Drug: GOM NS;   Drug: GMM-2 NS;   Drug: GSP 301 Placebo NS
3 Unknown  Efficacy and Safety of S0597 in Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Placebo;   Drug: S0597 low dose;   Drug: S0597 mid dose;   Drug: S0597 high dose;   Drug: Reference
4 Unknown  Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: montelukast;   Drug: cetirizine;   Drug: montelukast and cetirizine;   Drug: placebo
5 Recruiting Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
Condition: Rhinitis, Allergic, Seasonal
Interventions: Biological: MK-3641;   Biological: Placebo;   Drug: Self-injectable epinephrine;   Drug: Albuterol/Salbutamol;   Drug: Loratadine;   Drug: Olopatadine;   Drug: Mometasone furoate monohydrate
6 Unknown  Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Thai Population
Conditions: Rhinitis, Allergic, Perennial;   Rhinitis, Allergic, Seasonal;   Skin Prick Test
Intervention:
7 Recruiting A Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using Mobile EECs
Condition: Seasonal Allergic Rhinitis
Interventions: Biological: Placebo (0.5ml);   Biological: Placebo (1.0ml);   Biological: Grass MATA MPL (0.5ml) 5100SU;   Biological: Grass MATA MPL (1.0ml) 10200SU;   Biological: Grass MATA MPL (1.0ml) 18200SU;   Biological: Grass MATA (0.5ml) 5100SU
8 Recruiting Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Azelastine hydrochloride and Fluticasone propionate;   Drug: Dymista™;   Other: Placebo
9 Recruiting Contac Bien Z Adverse Effect Survey
Conditions: Allergic Rhinitis;   Seasonal Allergic Rhinitis
Intervention: Other: Cetrizine hydrochloride
10 Unknown  Allergic Rhinitis Changes the Sinus Microbiome
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: QNASL;   Drug: Placebo nasal spray
11 Not yet recruiting Effect of the Nasal Provocation on the Breathing Style
Conditions: Birch Pollen Allergy;   Healthy Control Subjects
Intervention: Biological: 1. session birch pollen nasal exposure 2. session xylometazoline nasal exposure
12 Unknown  Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy
Conditions: Birch Pollen Related Apple Allergy;   Birch Pollen Allergy
Interventions: Drug: rMal d 1;   Drug: rBet v 1;   Other: placebo drops
13 Unknown  Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Other: Grass pollen sublingual immunotherapy tablet;   Drug: Control
14 Not yet recruiting Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
Conditions: Rhinitis;   Rhinoconjunctivitis
Interventions: Biological: MG56 Mannosylated 5.000 subcutaneous;   Biological: MG56 Mannosylated 10.000 subcutaneous;   Biological: MG56 Mannosylated 30.000 subcutaneous;   Biological: MG56 Mannosylated 50.000 subcutaneous;   Biological: MG56 Mannosylated 5.000 sublingual;   Biological: MG56 Mannosylated 10.000 sublingual;   Biological: MG56 Mannosylated 30.000 sublingual;   Biological: MG56 Mannosylated 50.000 sublingual;   Biological: Subcutaneous placebo;   Biological: Sublingual placebo
15 Recruiting Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: Placebo;   Drug: Fluticasone propionate;   Drug: Fluticasone/Azelastine nasal spray;   Procedure: Nasal Allergen Challenge
16 Recruiting Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
Condition: Hay Fever
Interventions: Biological: Placebo solution;   Biological: gpASIT+TM
17 Not yet recruiting A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo
18 Not yet recruiting Efficacy and Safety of Sublingual Immunotherapy (SLIT)
Condition: Allergic Rhinitis
Interventions: Biological: sublingual immunotherapy with allergen extract;   Biological: sublingual immunotherapy with placebo
19 Recruiting Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen
Conditions: Allergic Rhinitis;   Asthma;   Latent Tuberculosis
Interventions: Other: TLR Agonist;   Other: Tuberculin nasal challenge;   Other: Timothy Grass Pollen
20 Not yet recruiting Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response
Condition: Hypersensitivity
Interventions: Biological: BM32;   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Indicates status has not been verified in more than two years